SKI Market

Indian Indices

Nifty

25,959.50 -108.65
(-0.42%)

Sensex

84,587.01 -313.70
( -0.37%)

Bank Nifty

58,835.35 -32.35
( -0.05%)

Nifty IT

37,037.95 152.60
( 0.41%)

Global Indices

Nasdaq

46,469.70 203.28
(0.44%)

Dow Jones

6,726.36 102.37
(1.55%)

Hang Seng

48,655.34 29.46
(0.06%)

Nikkei 225

9,569.96 30.25
(0.32%)

Forex

USD-INR

89.60 0.93
(1.05%)

EUR-INR

103.15 0.96
(0.94%)

GBP-INR

117.32 1.44
(1.24%)

JPY-INR

0.57 0.01
(1.69%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

Dr Reddys Laboratories Ltd

Industry : Pharmaceuticals - Indian - Bulk Drugs & Formln

BSE Code

ISIN Demat

Book Value()

500124

INE089A01031

377.5672424

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

DRREDDY

18.94

102220.23

EPS(TTM)

Face Value()

Div & Yield %

64.68

0.65

Back

R R Financial Consultants standalone net profit declines 40.00% in the September 2025 quarter

Nov 11,2025

Net profit of R R Financial Consultants declined 40.00% to Rs 0.06 crore in the quarter ended September 2025 as against Rs 0.10 crore during the previous quarter ended September 2024. Sales rose 33.33% to Rs 0.24 crore in the quarter ended September 2025 as against Rs 0.18 crore during the previous quarter ended September 2024.

Particulars	Quarter Ended
	Sep. 2025	Sep. 2024	% Var.
Sales	0.24	0.18	33
OPM %	79.17	61.11	-
PBDT	0.07	0.11	-36
PBT	0.07	0.11	-36
NP	0.06	0.10	-40

25,959.50 -108.65 (-0.42%)

84,587.01 -313.70 ( -0.37%)

58,835.35 -32.35 ( -0.05%)

37,037.95 152.60 ( 0.41%)

46,469.70 203.28 (0.44%)

6,726.36 102.37 (1.55%)

48,655.34 29.46 (0.06%)

9,569.96 30.25 (0.32%)

89.60 0.93 (1.05%)

103.15 0.96 (0.94%)

117.32 1.44 (1.24%)

0.57 0.01 (1.69%)